NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Disney has named its parks chief Josh D’Amaro to succeed Bob Iger as the entertainment giant’s top executive.Read More